Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000458284 | SCV000551162 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2023-05-21 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000679240 | SCV000805898 | uncertain significance | not provided | 2017-12-13 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000771457 | SCV000903874 | likely benign | Hereditary cancer-predisposing syndrome | 2016-04-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000771457 | SCV002624393 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-01-09 | criteria provided, single submitter | clinical testing | The p.K13R variant (also known as c.38A>G), located in coding exon 1 of the MSH6 gene, results from an A to G substitution at nucleotide position 38. The lysine at codon 13 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is highly conserved on limited sequence alignment. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV003463935 | SCV004195643 | uncertain significance | Endometrial carcinoma | 2023-07-23 | criteria provided, single submitter | clinical testing |